Jiangsu Lanfeng Bio-chemical Co.,Ltd

Shenzhen Stock Exchange 002513.SZ

Jiangsu Lanfeng Bio-chemical Co.,Ltd Operating Income for the year ending December 31, 2023: USD -48.83 M

Jiangsu Lanfeng Bio-chemical Co.,Ltd Operating Income is USD -48.83 M for the year ending December 31, 2023, a -206.74% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.

Jiangsu Lanfeng Bio-chemical Co.,Ltd Operating Income for the year ending December 31, 2022 was USD -15.92 M, a 80.98% change year over year.
Jiangsu Lanfeng Bio-chemical Co.,Ltd Operating Income for the year ending December 31, 2021 was USD -83.70 M, a -2,153.23% change year over year.
Jiangsu Lanfeng Bio-chemical Co.,Ltd Operating Income for the year ending December 31, 2020 was USD 4.08 M, a 21.51% change year over year.
Jiangsu Lanfeng Bio-chemical Co.,Ltd Operating Income for the year ending December 31, 2019 was USD 3.35 M, a 121.52% change year over year.

Key data

Date	Operating Income	EBIT	EBITDA	Net Income

Shenzhen Stock Exchange: 002513.SZ

Jiangsu Lanfeng Bio-chemical Co.,Ltd

CEO	Mr. Jun Xing
IPO Date	Dec. 3, 2010
Location	China
Headquarters	No. 1 Suhua Road
Employees	1,573
Sector	Health Care
Industries Pharmaceuticals Chemicals & Advanced Materials

Description

Jiangsu Lanfeng Bio-chemical Co.,Ltd researches, develops, produces, and sells pesticides, fungicides, insecticides, herbicides, and fine chemical intermediates in China and internationally. It offers thiophanate-methyl, cyclohexazone, benomyl, and carbendazim. The company is based in Xinyi, China.

Key trends

Past 5 years